Compare CRIS & MPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRIS | MPU |
|---|---|---|
| Founded | 2000 | 1989 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Transportation Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.6M | 18.0M |
| IPO Year | 2000 | 2023 |
| Metric | CRIS | MPU |
|---|---|---|
| Price | $0.37 | $0.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | 446.3K | ★ 8.6M |
| Earning Date | 05-07-2026 | 04-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.57 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $9,898,000.00 | N/A |
| Revenue This Year | $27.10 | N/A |
| Revenue Next Year | $67.74 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 31.50 | N/A |
| 52 Week Low | $0.38 | $0.21 |
| 52 Week High | $2.48 | $4.44 |
| Indicator | CRIS | MPU |
|---|---|---|
| Relative Strength Index (RSI) | 31.80 | 39.19 |
| Support Level | N/A | $0.21 |
| Resistance Level | $0.57 | $0.75 |
| Average True Range (ATR) | 0.05 | 0.10 |
| MACD | -0.00 | 0.00 |
| Stochastic Oscillator | 3.16 | 15.56 |
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
Mega Matrix Corp is a holding company that offers investors an opportunity to participate in the growth of stablecoins, one of the fastest-evolving sectors in digital assets. The company generated revenue from the Membership and top-up streaming services revenue, Online advertising services, and Content licensing. Geographically, the company operates in the United States and Canada, Asia Pacific, Europe middle east and Africa, and Latin America.